MENU
MLTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases... Show more
A.I. Advisor
published Earnings
MLTX is expected to report earnings to fall 7.18% to -77 cents per share on November 17
Q3'26
Est.
$-0.78
Q2'26
Beat
by $0.09
Q1'26
Missed
by $0.09
Q4'25
Beat
by $0.06
Q3'25
Missed
by $0.22
The last earnings report on August 10 showed earnings per share of -83 cents, beating the estimate of -93 cents. With 210.29K shares outstanding, the current market capitalization sits at 983.83M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
Who is the Most Widely Known Villain of Wall Street?
What is the Ladder Strategy for Structuring My Bond Portfolio?
What Does Opportunity Cost Mean?
What is pre-market trading and what are the benefits of participating in pre-market trading?
What is the fundamental definition of Keynesian Economics theory?
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
Dorfstrasse 29
Phone
+41 415108022
Employees
130
Web
https://www.moonlaketx.com